Immunological Analysis of Treatment Interruption After Early Highly Active Antiretroviral Therapy
We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active antiretroviral therapy (HAART). After treatment interruption (TI), some individuals could maintain a low plasma viral load (<15,000 copies/mL), whereas others could not (>50,000 copies/mL). Before H...
Saved in:
Published in | Viral immunology Vol. 23; no. 6; pp. 69 - 618 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Mary Ann Liebert, Inc
01.12.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We longitudinally evaluated HIV-specific T-cell immunity after discontinuation of highly active antiretroviral therapy (HAART). After treatment interruption (TI), some individuals could maintain a low plasma viral load (<15,000 copies/mL), whereas others could not (>50,000 copies/mL). Before HAART was initiated, plasma viral load was similar. After TI, the numbers of CD8
+
T cells increased more in individuals without viral control, whereas individuals maintaining a low viral load showed a more pronounced increase in HIV-specific CD8
+
T-cell numbers. No differences were seen in the number or percentage of cytokine-producing HIV-1-specific CD4
+
T cells, or in proliferative capacity of T cells. Four weeks after TI, the magnitude of the total HIV-1-specific CD8
+
T-cell response (IFN-γ
+
and/or IL-2
+
and/or CD107a
+
) was significantly higher in individuals maintaining viral control. Degranulation contributed more to the overall CD8
+
T-cell response than cytokine production. Whether increased T-cell functionality is a cause or consequence of low viral load remains to be elucidated. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0882-8245 1557-8976 |
DOI: | 10.1089/vim.2010.0062 |